GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Better Therapeutics BTTX · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

0.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Better Therapeutics — daily BTTX Delayed
Market value
$4,986
Last close × shares
Volume
500
Shares, 9 Nov 2026

About Better Therapeutics

Its shares trade under the ticker BTTX. It has been listed since 8 January 2021. In the fiscal year to 31 December 2020, it reported revenue of $8,000 and a net loss of $6.4m. At that date it held total assets of $6.4m and shareholders' equity of −$6.8m.

Better Therapeutics, Inc. operates as a digital therapeutics company, which engages in developing a novel form of cognitive behavioral therapy to address the root causes of cardio metabolic diseases. The company is headquartered in San Francisco, California. The company went IPO on 2021-01-08. The firm is engaged in developing a novel form of cognitive behavioral therapy (CBT) to address the root causes of cardiometabolic diseases. Its lead PDT product candidate, BT-001, is an investigational prescription digital therapy for the treatment of T2D. The investigational therapy is delivered via software that provides a tailored experience to patients designed to help them address the underlying causes of T2D by making meaningful, sustainable behavioral changes. The BT-001 investigational therapy is rooted in the well-studied, gold standard of behavioral modification therapies, cognitive behavioral therapy (CBT). The firm's platform consists of three behavioral therapy, treatment plans and personalization. Its behavioral therapy consists of lessons, skill- building modules, and a mechanism for goal setting. Its treatment plan is the primary engagement interface for patients.

Figures and description from our data supplier, not checked against the company's own report.

More about Better Therapeutics →

Latest on Better Therapeutics

Our reporting

We have not reported on Better Therapeutics yet.

Next results

12 Nov 2026

Due on 12 Nov 2026. Analysts expect earnings of -0.21 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Better Therapeutics's ticker?

Better Therapeutics trades as BTTX on its US listing, under ISIN US08773T1043.

What was Better Therapeutics's last closing price?

0.00 on 9 Nov 2026. The figure is in USD and is never converted.

When does Better Therapeutics next report results?

Results are expected on 12 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.